{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:19:54Z","timestamp":1790623194707,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1378\/chest.122.2.510","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"510-516","source":"Crossref","is-referenced-by-count":181,"title":["Lung Deposition of Hydrofluoroalkane-134a Beclomethasone Is Greater Than That of Chlorofluorocarbon Fluticasone and Chlorofluorocarbon Beclomethasone"],"prefix":"10.1016","volume":"122","author":[{"given":"Chet L.","family":"Leach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Hasselquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.122.2.510_bib1","series-title":"Global initiative for asthma: global strategy for asthma management and prevention; NHLBI\/WHO Workshop Report","author":"National Heart, Lung, and Blood Institute","year":"1995"},{"key":"10.1378\/chest.122.2.510_bib2","first-page":"3","article-title":"The relevance of and site of airway inflammation in asthma and targeted aerosol delivery","volume":"106","author":"Howarth","year":"1999","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1378\/chest.122.2.510_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0091-6749(97)70193-3","article-title":"Inflammation of small airways in asthma","volume":"100","author":"Hamid","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.122.2.510_bib4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1164\/ajrccm.154.3.8810618","article-title":"Glucocorticoid receptor localization in normal and asthmatic lung","volume":"154","author":"Adcock","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.122.2.510_bib5","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1183\/09031936.98.12061346","article-title":"Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone","volume":"12","author":"Leach","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.122.2.510_bib6","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1067\/mai.2000.111582","article-title":"Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma","volume":"106","author":"Vanden Burgt","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.122.2.510_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-5173(99)00133-7","article-title":"A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers","volume":"186","author":"Gabrio","year":"1999","journal-title":"Int J Pharm"},{"issue":"suppl 30","key":"10.1378\/chest.122.2.510_bib8","first-page":"196s","article-title":"Lung deposition characteristics of HFA-134a beclomethasone dipropionate delivered via an autohaler [abstract]","volume":"14","author":"Conway","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.122.2.510_bib9","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1016\/S0091-6749(98)70155-1","article-title":"Development of fluticasone propionate and comparison with other inhaled corticosteroids","volume":"101","author":"Johnson","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.122.2.510_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1398-9995.1998.tb03951.x","article-title":"Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in peripheral blood of patients with asthma","volume":"53","author":"Bootsma","year":"1998","journal-title":"Allergy"},{"key":"10.1378\/chest.122.2.510_bib11","first-page":"56276","article-title":"The Montreal Protocol. The Montreal Protocol on substances that deplete the ozone layer: final Act (Nairobi: UNEP, 1987)","volume":"59","year":"1994","journal-title":"Fed Reg"},{"key":"10.1378\/chest.122.2.510_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000195399","article-title":"New method for easy labelling of \u03b2-2-agonists in the metered dose inhaler with technetium 99m","volume":"53","author":"Ko\u00a8hler","year":"1988","journal-title":"Respiration"},{"key":"10.1378\/chest.122.2.510_bib13","first-page":"A177","article-title":"Lung deposition of 18F-fluticasone propionate in normal subjects using positron emission tomography (PET) [abstract]","volume":"161","author":"Rahman","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.122.2.510_bib14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(99)03581-3","article-title":"Differences in lung bioavailability between different propellants for fluticasone propionate","volume":"354","author":"Wilson","year":"1999","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1378\/chest.122.2.510_bib15","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1089\/jam.1998.11.Suppl_1.S-29","article-title":"Relevance of radiolabeled steroid inhalation studies to clinical outcomes","volume":"11","author":"Leach","year":"1998","journal-title":"J Aerosol Med"},{"issue":"suppl B","key":"10.1378\/chest.122.2.510_bib16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0954-6111(00)90147-1","article-title":"Pharmaceutical transition to non-CFC pressurized metered dose inhalers","volume":"94","author":"Cripps","year":"2000","journal-title":"Respir Med"},{"key":"10.1378\/chest.122.2.510_bib17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0091-6749(99)70016-3","article-title":"Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant","volume":"104","author":"Busse","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.122.2.510_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1378\/chest.115.2.343","article-title":"Hydrofluoroalkane-134a beclomethasone dipropionate, 400 \u03bcg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 \u03bcg, for the treatment of moderate asthma","volume":"115","author":"Gross","year":"1999","journal-title":"Chest"},{"issue":"suppl A","key":"10.1378\/chest.122.2.510_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0954-6111(98)90214-1","article-title":"Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose","volume":"92","author":"Davies","year":"1998","journal-title":"Respir Med"},{"key":"10.1378\/chest.122.2.510_bib20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1053\/rmed.1999.0772","article-title":"Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol: Comparative Inhaled Steroid Investigation Group","volume":"94","author":"Magnussen","year":"2000","journal-title":"Respir Med"},{"key":"10.1378\/chest.122.2.510_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1742-1241.1999.tb11741.x","article-title":"Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers","volume":"53","author":"Demedts","year":"1999","journal-title":"Int J Clin Pract"},{"key":"10.1378\/chest.122.2.510_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1081-1206(10)62905-5","article-title":"Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol","volume":"86","author":"Fireman","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl D","key":"10.1378\/chest.122.2.510_bib23","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0954-6111(00)90122-7","article-title":"The relative clinical effectiveness of HFA-BDP and fluticasone propionate in asthma","volume":"94","author":"Fairfax","year":"2000","journal-title":"Respir Med"},{"key":"10.1378\/chest.122.2.510_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1081-1206(10)62907-9","article-title":"A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate","volume":"86","author":"Fairfax","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1378\/chest.122.2.510_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/rmed.2000.1025","article-title":"Efficacy of HFA-beclomethasone dipropionate extrafine aerosol (800 microg\/day) vs HFA-fluticasone propionate (1000 microg\/day) in patients with asthma","volume":"95","author":"Aubier","year":"2001","journal-title":"Respir Med"},{"key":"10.1378\/chest.122.2.510_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0954-6111(98)90039-7","article-title":"Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less","volume":"92","author":"Barnes","year":"1998","journal-title":"Respir Med"},{"key":"10.1378\/chest.122.2.510_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2125.1997.d01-1425.x","article-title":"Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects","volume":"43","author":"Thorsson","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1378\/chest.122.2.510_bib28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0039-128X(94)90054-X","article-title":"Binding kinetics of fluticasone propionate to the human glucocorticoid receptor","volume":"59","author":"Ho\u00a8gger","year":"1994","journal-title":"Steroids"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215513809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215513809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T22:09:32Z","timestamp":1734041372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215513809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0012369215513809"],"URL":"https:\/\/doi.org\/10.1378\/chest.122.2.510","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}